Literature DB >> 31033250

Validation of the 36-item and 12-item self-report World Health Organization Disability Assessment Schedule II (WHODAS-II) in individuals with autism spectrum disorder.

Shin Ho Park1, Eleni A Demetriou1, Karen L Pepper1, Yun Ju C Song1, Emma E Thomas1, Ian B Hickie1,2, Nick Glozier1, Adam J Guastella1.   

Abstract

The World Health Organization Disability Assessment Schedule II (WHODAS-II) is one of the most widely used generic assessments for measuring disability levels in both clinical and nonclinical populations, with sound psychometrics that is also aligned with the International Classification of Functioning framework. However, its psychometric properties have not been explored extensively in individuals with autism spectrum disorder (ASD). This study examined the psychometric properties of the 36-item and 12-item Self-Report WHODAS-II from 109 individuals diagnosed with ASD and without intellectual disability (IQ ≥ 70). Participants were consecutively recruited from the Brain and Mind Centre in New South Wales, Australia. The WHODAS-II showed adequate internal consistency for all domain scores (α = 0.78-0.97 for 36-item) and for the summary scale (α = 0.95 for 36-item; 0.86 for 12-item). All items also exhibited satisfactory correlations with their respective domain (r = 0.39-0.94 for 36-item) and summary scores (r = 0.42-0.71 for 36-item; 0.42-0.67 for 12-item), except item 4.5 "sexual activity" from the 36-item WHODAS-II (r = 0.19). Concurrent validity was shown by moderate correlations between similar constructs across the WHODAS-II and the World Health Organization Quality of Life BREF (Ps < 0.05). The second-order 7-factor model showed the best fit for the 36-item WHODAS-II, while the second-order 6-factor model demonstrated an acceptable fit for the 12-item WHODAS-II. The model fit could be improved with some modifications. The Schmid-Leiman transformation further confirmed the appropriateness of the second-order factor structure. Overall, the results indicated that the WHODAS-II is a viable generic self-report measure for disability in autistic individuals without ID. Autism Res 2019, 12: 1101-1111.
© 2019 International Society for Autism Research, Wiley Periodicals, Inc. LAY SUMMARY: The majority of autistic people have a disability with a profound or severe limitation in their core activities. However, there is currently limited research identifying reliable and valid self-report measures for disability in the autistic population. This study examined the psychometric properties of the World Health Organization Disability Assessment Schedule II (WHODAS-II) from 109 autistic individuals without intellectual disability. Our results suggest that the WHODAS-II is a viable generic self-report measure for disability in autistic individuals. © 2019 International Society for Autism Research, Wiley Periodicals, Inc.

Entities:  

Keywords:  WHODAS; autism spectrum disorder; disability; internal consistency; validity

Year:  2019        PMID: 31033250     DOI: 10.1002/aur.2115

Source DB:  PubMed          Journal:  Autism Res        ISSN: 1939-3806            Impact factor:   5.216


  4 in total

1.  Evaluating the Use of Self-reported Measures in Autistic Individuals in the Context of Psychiatric Assessment: A Systematic Review.

Authors:  Soo Youn Kim; Luc Lecavalier
Journal:  J Autism Dev Disord       Date:  2021-10-13

2.  Psychometric properties of the Polish version of the 36-item WHODAS 2.0 in patients with hip and knee osteoarthritis.

Authors:  Agnieszka Bejer; Agnieszka Ćwirlej-Sozańska; Agnieszka Wiśniowska-Szurlej; Anna Wilmowska-Pietruszyńska; Renata Spalek; Alessandro de Sire; Bernard Sozański
Journal:  Qual Life Res       Date:  2021-03-15       Impact factor: 4.147

3.  Caregiver Burden and Disability in Somatoform Disorder: An Exploratory Study.

Authors:  Esther Chinneimawi; Padmavathi Nagarajan; Vikas Menon
Journal:  Indian J Psychol Med       Date:  2020-11-02

4.  Psychometric properties and validation of the polish version of the 12-item WHODAS 2.0.

Authors:  Agnieszka Ćwirlej-Sozańska; Bernard Sozański; Hubert Kotarski; Anna Wilmowska-Pietruszyńska; Agnieszka Wiśniowska-Szurlej
Journal:  BMC Public Health       Date:  2020-08-05       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.